CLASS II ONGOING Device recall · Reported 15 Oct 2025 · FDA Enforcement Report

Artegraft Collagen Vascular Graft recalled by LeMaitre Vascular

LeMaitre Vascular is recalling Artegraft Collagen Vascular Graft. The recall was initiated on 25 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel/Catalog/Part Number, UDI-DI (lot Numbers): 1. AG630M, 00316837000015 (24H361-021, 24H361-022, 24HH359-016). 2. AG636M, 00316837000022 (24H380-009). 3. AG730M, 00316837000060 (24H380-014, 24H380-004). 4. AG740M, 00316837000084 (24H380-003, 24H380-002). 5. AG845M, 00316837000138 (24HH350-017, 24HH359-011). Expiration date: 28 Jul 2027.
Quantity recalled10 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0072-2026
FDA event ID
97567
Recalling firm
LeMaitre Vascular, North Brunswick, NJ
Classification
Class II
Status
Ongoing
Recall initiated
25 Aug 2025
FDA classified
8 Oct 2025
Reported
15 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Labeling Errors

Timeline

25 Aug 2025Recall initiated by company
8 Oct 2025Classified by FDA+44 days
15 Oct 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.

Product as listed by the FDA

Artegraft Collagen Vascular Graft. Model/Catalog/Part Numbers: AG630M, AG636M, AG730M, AG740M, AG845M. The Artegraft is intended to serve as a substitute conduit for blood where bypass or replacement of occluded or diseased arterial segments is required or to establish a conduit for hemodialysis.

Where it was distributed

No US distribution. International distribution to Great Britian and Switzerland.

Questions about this recall

Why was it recalled?

Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.

Which lots are affected?

Model/Catalog/Part Number, UDI-DI (lot Numbers): 1. AG630M, 00316837000015 (24H361-021, 24H361-022, 24HH359-016). 2. AG636M, 00316837000022 (24H380-009). 3. AG730M, 00316837000060 (24H380-014, 24H380-004). 4. AG740M, 00316837000084 (24H380-003, 24H380-002). 5. AG845M, 00316837000138 (24HH350-017, 24HH359-011). Expiration date: 28 Jul 2027.

Where was it sold?

No US distribution. International distribution to Great Britian and Switzerland.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from LeMaitre Vascular

All 71

Other Heart & Vascular Devices recalls

All 6,220